Regulation of P-glycoprotein and Breast Cancer Resistance Protein Expression Induced by Focused Ultrasound-Mediated Blood-Brain Barrier Disruption: A Pilot Study.
Allegra ContiFrancoise GeffroyHermes A S KamimuraAnthony NovellNicolas TournierSébastien MériauxBenoit LarratPublished in: International journal of molecular sciences (2022)
The blood-brain barrier (BBB) controls brain homeostasis; it is formed by vascular endothelial cells that are physically connected by tight junctions (TJs). The BBB expresses efflux transporters such as P-glycoprotein (P-gp) and breast cancer resistance protein (BCRP), which limit the passage of substrate molecules from blood circulation to the brain. Focused ultrasound (FUS) with microbubbles can create a local and reversible detachment of the TJs. However, very little is known about the effect of FUS on the expression of efflux transporters. We investigated the in vivo effects of moderate acoustic pressures on both P-gp and BCRP expression for up to two weeks after sonication. Magnetic resonance-guided FUS was applied in the striatum of 12 rats. P-gp and BCRP expression were determined by immunohistochemistry at 1, 3, 7, and 14 days postFUS. Our results indicate that FUS-induced BBB opening is capable of (i) decreasing P-gp expression up to 3 days after sonication in both the treated and in the contralateral brain regions and is capable of (ii) overexpressing BCRP up to 7 days after FUS in the sonicated regions only. Our findings may help improve FUS-aided drug delivery strategies by considering both the mechanical effect on the TJs and the regulation of P-gp and BCRP.
Keyphrases
- blood brain barrier
- poor prognosis
- cerebral ischemia
- magnetic resonance
- drug delivery
- binding protein
- resting state
- white matter
- functional connectivity
- magnetic resonance imaging
- high glucose
- high intensity
- multiple sclerosis
- oxidative stress
- high resolution
- newly diagnosed
- vascular endothelial growth factor
- drug release
- protein protein